Download PDF
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2021; 11(03): 178-187
DOI: 10.1055/s-0041-1726692
Original Article

Preliminary Evidence from a Cross-sectional Study on Epidemiology and Early Transmission Dynamics of COVID-19 in Karnataka State of India

Bakilapadavu Venkatraja
1   Department of Economics, Shri Dharmasthala Manjunatheshwara Institute for Management Development, Mysuru, Karnataka, India
,
Gali Srilakshminarayana
2   Department of Quantitative Methods, Shri Dharmasthala Manjunatheshwara Institute for Management Development, Mysuru, Karnataka, India
,
Ballamoole Krishna Kumar
3   Division of Infectious Diseases, Nitte University Centre for Science Education and Research, Nitte (deemed to be) University, Deralakatte, Mangaluru, Karnataka, India
,
Madhura Nagesh Hegde
4   Department of Information Science and Engineering, Sahyadri College of Engineering and Management, Mangaluru, Karnataka, India
,
Jayapadmini Kanchan
4   Department of Information Science and Engineering, Sahyadri College of Engineering and Management, Mangaluru, Karnataka, India
,
Ganaraj Karuvaje
4   Department of Information Science and Engineering, Sahyadri College of Engineering and Management, Mangaluru, Karnataka, India
,
Praveen Rai
3   Division of Infectious Diseases, Nitte University Centre for Science Education and Research, Nitte (deemed to be) University, Deralakatte, Mangaluru, Karnataka, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction Coronavirus disease 2019 (COVID-19) is an emerging infection and quickly disseminated around the world. This article studies the epidemiology and early transmission dynamics of COVID-19 in Karnataka, which would be useful for effective epidemic management and policy formulation.

Materials and Methods All COVID-19 cases reported in the state of Karnataka, India, till June 12, 2020, are included in the study. The epidemiology and transmission dynamics of COVID-19 in Karnataka is studied through descriptive statistical analysis.

Results The findings illustrate a gender-, age-, and region-based disparity in the susceptibility and fatality. There appears to be a male preponderance in the susceptibility, but a female preponderance in fatality. It is also found that the adults are more susceptible to the infection, while the elderly have the risk of high fatality. Further, infected individuals in the region with urbanization have a higher risk of fatality than other regions. The study shows that the chances of recovery for females are lower than males, and further, the chances of recovery are positively related to the age of the infected person. The chances of recovery are higher if the infected individual is younger and they diminish if the individual is older. The study also explores that the chances of recovery are affected by the patient’s geographical location. It is also noted that individuals who returned from foreign travel have better chances of recovery than the locally transmitted individuals.

Conclusion Though the risk of susceptibility to COVID-19 infection is equal to all, the burden of getting infected and the burden of fatality is unequally distributed among different demographic categories. To manage the contagious spread of epidemic, to reduce fatality, and to increase the chances of recovery, targeted policy actions are suggested to benefit the vulnerable demographic categories.

Keywords

COVID-19 - health status - fatality - CFR - demography - epidemiology - Karnataka


Publication History

Article published online:
11 May 2021

© 2021. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dawood FS, Ricks P, Njie GJ. et al. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis. Lancet Infect Dis 2020; 20 (11) 1255-1262
    CrossrefPubMedGoogle Scholar
  • 2 Situation Report WHO. 2020. https://apps.who.int/iris/handle/10665/333905. Accessed March 9, 2021
  • 3 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (102/23) 497-506
    CrossrefPubMedGoogle Scholar
  • 4 Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021; 19 (03) 141-154
    CrossrefPubMedGoogle Scholar
  • 5 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
    CrossrefPubMedGoogle Scholar
  • 6 Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 2007; 170 (04) 1136-1147
    CrossrefPubMedGoogle Scholar
  • 7 Dhama K, Patel SK, Pathak M. et al. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis 2020; 37: 101755
    CrossrefPubMedGoogle Scholar
  • 8 Andrews MA, Areekal B, Rajesh KR. et al. First confirmed case of COVID-19 infection in India: A case report. Indian J Med Res 2020; 151 (05) 490-492
    CrossrefPubMedGoogle Scholar
  • 9 Yadav PD, Potdar VA, Choudhary ML. et al. Full-genome sequences of the first two SARS-CoV-2 viruses from India. Indian J Med Res 2020; 151 (02/03) 200-209
    CrossrefPubMedGoogle Scholar
  • 10 Khan MI, Khan ZA, Baig MH. et al. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLoS One 2020; 15 (09) 0238344
    Google Scholar
  • 11 Kumar BK, Venkatraja B, Prithvisagar KS. prpt. et al. Mutational analysis unveils the temporal and spatial distribution of G614 genotype of SARS-CoV-2 in different Indian states and its association with case fatality rate of COVID-19.bioRxiv 2020. DOI: 10.1101/2020.07.27.222562/prpt.
    Google Scholar
  • 12 Parlikar A, Kalia K, Sinha S. et al. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2. PeerJ 2020; 8: e9576
    CrossrefPubMedGoogle Scholar
  • 13 Joe W, Kumar A, Rajpal S, Mishra US, Subramanian SV. Equal risk, unequal burden? Gender differentials in COVID-19 mortality in India. J Glob Health Sci 2020; 2 (01) DOI: 10.35500/jghs.2020.2.e17.
    CrossrefGoogle Scholar
  • 14 Lipsitch M, Donnelly CA, Fraser C. et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis 2015; 9 (07) 0003846
    CrossrefPubMedGoogle Scholar
  • 15 Russell TW, Hellewell J, Jarvis CI. et al. Cmmid Covid-Working Group. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Euro Surveill 2020; 25 (12) 2000256
    CrossrefPubMedGoogle Scholar
  • 16 Garg S, Kim L, Whitaker M. et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR. 2020; 69 (15) 458-464
    PubMedGoogle Scholar
  • 17 Guo YR, Cao QD, Hong ZS. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res 2020; 7 (01) 1-0
    PubMedGoogle Scholar
  • 18 Vigo D, Thornicroft G, Gureje O. The differential outcomes of coronavirus disease 2019 in low- and middle-income countries vs high-income countries. JAMA Psychiatry 2020; 77 (12) 1207-1208
    CrossrefPubMedGoogle Scholar
  • 19 Mi YN, Huang TT, Zhang JX. et al. Estimating the instant case fatality rate of COVID-19 in China. Int J Infect Dis 2020; 97: 1-6
    CrossrefPubMedGoogle Scholar
  • 20 IBEF-India Brand Equity Foundation newsletter on industrial development and economic growth in Karnataka. 2020. https://www.ibef.org/states/karnataka-presentation. Accessed March 9, 2021
  • 21 The Lancet. India under COVID-19 lockdown. Lancet 2020; 395 (10233) 1315
    CrossrefPubMedGoogle Scholar
  • 22 Chetterje P. Gaps in India’s preparedness for COVID-19 control. Lancet Infect Dis 2020; 20 (05) 544
    CrossrefPubMedGoogle Scholar
  • 23 Sardar T, Nadim SS, Rana S. Chattopadhyay J. Assessment of lockdown effect in some states and overall India: A predictive mathematical study on COVID-19 outbreak. Chaos Solitons Fractals 2020; 139: 110078
    CrossrefPubMedGoogle Scholar
  • 24 Mahajan P, Kaushal J. Epidemic trend of COVID-19 transmission in India during lockdown-1 Phase. J Community Health 2020; 45 (06) 1291-1300
    CrossrefPubMedGoogle Scholar
  • 25 Mandal S, Bhatnagar T, Arinaminpathy N. et al. Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach. Indian J Med Res 2020; 151 (02/03) 190-199
    CrossrefPubMedGoogle Scholar
  • 26 Walter LA, McGregor AJ. McGregorAJ. Sex- and gender-specific observations and implications for COVID-19. West J Emerg Med 2020; 21 (03) 507-509
    CrossrefPubMedGoogle Scholar
  • 27 Smith J, Griffith D, White A. et al. COVID-19, equity and men’s health. Int J Mens Soc Comm Health. 2020; 3 (01) e48-e64
    CrossrefGoogle Scholar
  • 28 Jin JM, Bai P, He W. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020; 8: 152
    CrossrefPubMedGoogle Scholar
  • 29 Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016; 16 (10) 626-638
    CrossrefPubMedGoogle Scholar
  • 30 Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol 2020; 20 (07) 442-447
    CrossrefPubMedGoogle Scholar
  • 31 Bwire GM. Coronavirus: why men are more vulnerable to COVID-19 than women?. SN Compr Clin Med 2020; 7: 1-3
    Google Scholar
  • 32 Foresta C, Rocca MS, Di ANisio. Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome.. J Endocrinol Invest 2020; 16: 1-6
    Google Scholar
  • 33 Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and gender-based differences in COVID-19. Front Public Health 2020; 8: 418
    CrossrefPubMedGoogle Scholar
  • 34 Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM. CMMID COVID-19 working group. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med 2020; 26 (08) 1205-1211
    CrossrefPubMedGoogle Scholar
  • 35 Dong Y, Mo X, Hu Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145 (06) e2020-0702
    CrossrefPubMedGoogle Scholar
  • 36 Heald-Sargent T, Muller WJ, Zheng X. et al. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19).. JAMA Pediatr 2020; 174 (09) 902-903
    CrossrefPubMedGoogle Scholar
  • 37 Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; 323 (18) 1775-1776
    PubMedGoogle Scholar
  • 38 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13) 1239-1242
    CrossrefPubMedGoogle Scholar
  • 39 Bonanad C, García-Blas S, Tarazona-Santabalbina F. et al. The effect of age on mortality in patients with Covid-19: a metaanalysis with 611,583 subjects. J Am Med Dir Assoc 2020; 21 (07) 915-918
    CrossrefPubMedGoogle Scholar